300 Phospholipase D/nuclease
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Homogeneous metal compounds | 5 | 6.3 | 0.80× | q = 0.66 | |
| Mixed metal/non-metal compounds | 4 | 0.3 | 15× | not tested | |
| Organic nitrogen compounds | 1 | 0.4 | 2.45× | not tested | |
| Benzenoids | 2 | 0.9 | 2.13× | not tested | |
| Homogeneous non-metal compounds | 5 | 2.8 | 1.81× | not tested | |
| Lipids and lipid-like molecules | 2 | 1.4 | 1.40× | not tested | |
| Organoheterocyclic compounds | 2 | 2.0 | 1.01× | not tested | |
| Organic acids and derivatives | 2 | 2.0 | 1.01× | not tested | |
| Organic oxygen compounds | 2 | 2.6 | 0.78× | not tested | |
| Nucleosides, nucleotides, and analogues | 1 | 3.5 | 0.28× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00127 | SPM | Spermine | 8 |
| DB03434 | MPO | 3-(N-morpholino)propanesulfonic acid | 8 |
| DB00122 | — | Choline | 4 |
| DB00171 | ATP | ATP | 4 |
| DB14006 | — | — | 4 |
| DB07898 | HI5 | (2R)-3-[(tetrahydroxyphosphoranyl)oxy]-1,2-propanediyl dibutanoate | 2 |
| DB08376 | PD7 | (2R)-3-(phosphonooxy)propane-1,2-diyl diheptanoate | 2 |
| DB09459 | TLA | L-tartaric acid | 2 |
| DB14756 | SRT | meso-Tartaric acid | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| VO4 | VANADATE ION | 36 |
| OTS | 4-(2S-AMINO-1-HYDROXYETHYL)PHENOL | 20 |
| CL | CHLORIDE ION | 17 |
| NAmetal | SODIUM ION | 12 |
| GHM | benzene-1,2,4-tricarboxylic acid | 8 |
| GJP | 4-hydroxyquinoline-3-carboxylic acid | 8 |
| MPO | 3[N-MORPHOLINO]PROPANE SULFONIC ACID | 8 |
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 8 |
| OTR | 4-(2R-AMINO-1-HYDROXYETHYL)PHENOL | 8 |
| PO3 | PHOSPHITE ION | 8 |
| SPM | SPERMINE | 8 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 6 |
| IPD | D-MYO-INOSITOL-1-PHOSPHATE | 6 |
| VHY | (2R)-3-(phosphonooxy)propane-1,2-diyl dibutanoate | 6 |
| WO4 | TUNGSTATE(VI)ION | 6 |
| ZNmetal | ZINC ION | 6 |
| IOD | IODIDE ION | 5 |
| A1AIM | (8M)-8-{4-(benzylcarbamoyl)-2-[(fluorosulfonyl)oxy]phenyl}-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | 4 |
| GJS | 4-hydroxybenzene-1,2-dicarboxylic acid | 4 |
| GM7 | 4-aminobenzene-1,2-dicarboxylic acid | 4 |